Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Research and Markets: A Competitor Analysis Report of Toll-Like Receptor (TLR) Agonists & Antagonists


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-09-03 23:53:01 -

www.researchandmarkets.com - Research and Markets (www.researchandmarkets.com/research/4af4b3/competitor_analysi) has announced the addition of the "Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists" report to their offering.

The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, RNA and vaccines targeting the toll-like receptors TLR3, TLR4, TLR5, TLR7,

TLR8 and TLR9 for treatment of cancer, infectious diseases, sepsis and allergy. The analysis details molecules targeting one or more of the toll-like receptors and includes agonists, antagonists as well as vaccines and vaccine adjuvants. TLR Agonists as well as TLR Antagonists are presented sorted by receptor subtype and by therapeutic area.

A list of TLR Adjuvants used in marketed vaccines and in vaccines under development is provided. TLR-adjuvanted vaccines are compiled sorted by TLR receptor subtype and by therapeutic area as prophylactic and therapeutic vaccines. The corporate R&D portfolios (more than one project) for TLR Agonists, Antagonists, Adjuvants and TLR-Adjuvanted Vaccines is contained in this Competitor Analysis. -0- The report includes a compilation of current active projects in the research and development of TLR agonists, antagonists, adjuvants and vaccines. Competitor projects are listed in a tabular format providing information on: - Drug Codes, - Target / Mechanism of Action, - Class of Compound, - Company, - Therapeutic Area, - Product Category, - Indication, - R&D Stage and - additional comments with a hyperlink leading to the source of information. Key Topics Covered: - TLR Agonists by Receptor Subtype - TLR Agonists by Therapeutic Area - TLR Antagonists - by Receptor Subtype - TLR Antagonists - by Therapeutic Area - TLR Adjuvants by Receptor Subtype - TLR-Adjuvanted Vaccines - by Receptor Subtype - TLR-Adjuvanted Vaccines - by Therapeutic Area - Corporate TLR Agonist & Antagonist R&D Portfolios Companies Mentioned: - 3M Drug Delivery Services - Allergy Therapeutics - Ampligen - Anadys Pharmaceuticals - Cytos Biotechnology - Dynavax Technologies - GlaxoSmithKline - Idera Pharmaceuticals - Index Pharmaceuticals - Innate Pharma - Intercell - Juvaris Biotherapeutics - Meda - Merck & Co. - Merck Serono - Multicell Technologies - Novartis - Nventa Biopharmaceuticals - OM Pharma - Pfizer - Vaxart - VaxInnate - VentiRx

For more information visit www.researchandmarkets.com/research/4af4b3/competitor_analysi.

Research and Markets Ltd.
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716


Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com